Cambridge Healthtech Institute’s Second Annual
Peptide Therapeutics
Conquering Disease
Part of the 11th Annual PEGS: the essential protein engineering summit
May 6-7, 2015 | World Trade Center | Boston, Massachusetts


By 2018, the global Peptide Therapeutics market is expected to reach over $25 billion. This dramatic market increase is driven by both growing incidences of cardiovascular and metabolic diseases, and technological enhancements in peptide synthesis that include high-throughput approaches. Hybrid technology combining solid and liquid syntheses is also contributing to the growth of peptide therapeutics, as are novel modes of conjugation.

This meeting will explore the burgeoning world of Peptide Therapeutics and how peptides are being engineered to penetrate cancer tumors and conquer unmet medical needs. Improving peptide properties, such as stability and half-life, will also be discussed along with innovating routes of administration. Case studies will be presented that illustrate the progress made in developing efficacious peptide therapeutics, while leaders in the field point the way to the future for these promising drugs.

Topics may include, but are not limited to: 

  • Peptide Therapeutic applications, including:
    • Cancer
    • Metabolic
    • Cardiovascular
    • Dermatology
    • Anti-Infection
    • Neurology
    • Gastro Intestinal
    • Renal
    • Respiratory
    • Pain
  • Targeted therapies
  • Stabilization
  • Half-life extension
  • Enhancing potency and cell permeability
  • Protein-protein interactions
  • Technological trends in R&D
  • Predictive modeling
  • Computational approaches to designing peptide therapeutics
  • Synthetic peptides
  • Stapled peptides
  • Cyclic peptides
  • Peptide fusions & bioconjugation
  • Multidisulfides, protein-peptide conjugates & RNA-peptide conjugates
  • Drug delivery
  • Routes of administration (Parenteral, Oral, Pulmonary, Mucosal)
  • Bioavailability
  • Mechanisms of action
  • Proteolytic cleavage
  • Glycosylation and acetylation
  • Phosphorylation
  • Cell line production & manufacturing challenges
  • Liquid Phase Peptide Synthesis (LPPS)
  • Solid Phase Peptide Synthesis (SPPS)
  • Hybrid
  • High-throughput synthesis and purification
  • Regulatory environment for peptide-based therapeutics

Peptide Researchers who wish to present their knowledge and expertise to their colleagues are asked to click here to submit an abstract. Remember to specify the conference that you are interested in and please provide your full contact information.

The deadline for submission is October 3, 2014 

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships. 

For more details on the conference, please contact:
Mary Ruberry
Conference Director
Cambridge Healthtech Institute
T: 781-972-5421
E: mruberry@healthtech.com 

For partnering and sponsorship information, please contact:
Jason Gerardi (Companies A-K)
Manager, Business Development
Cambridge Healthtech Institute
T: 781-972-5452
E: jgerardi@healthtech.com 

Carol Dinerstein (Companies L-Z)
Director, Business Development
Cambridge Healthtech Institute
T: 781.972.5471
E: dinerstein@healthtech.com